MRM
Medirom Healthcare Technologies Inc.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- R May 29 Medirom Healthcare Technologies disclosed receipt of a Nasdaq defici…
- X Jul 31 Short interest falls 47.9% to 37.1K
- R Aug 7 Medirom Healthcare Technologies (MRM) disclosed that Nasdaq granted…
- X Aug 14 Short interest falls 25.5% to 27.6K
- X Aug 31 Short interest falls 34.4% to 18.1K
- X Sep 15 Short interest falls 28.1% to 13.0K
- X Sep 30 Short interest falls 78.6% to 2.8K
- R Oct 13 Medirom Healthcare Technologies Inc. disclosed receipt of a Nasdaq d…
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- InstitutionsMIXED
Q2 2026: 2 added (0 new), 0 trimmed or exited.
- TrendDOWNTREND
48% below its 50-day average.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| HRT FINANCIAL LP | DOUBLED | $56.0K |
| RHUMBLINE ADVISERS | ADD | $3.2K |
| UBS Group AG | DOUBLED | $29.7K |
| RHUMBLINE ADVISERS | TRIM | $2.2K |
| RHUMBLINE ADVISERS | DOUBLED | $8.3K |
| UBS Group AG | TRIM | $47.3K |
| UBS Group AG | DOUBLED | $36.2K |
| UBS Group AG | DOUBLED | $46.5K |
Quarterly 13F filings are due 45 days after each quarter ends.
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Aug 27, 2026 | Eguchi Kouji Chief Executive Officer | OTHER | 79,945 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026SecBot reports
6 filings · 0 bullish · 4 bearish · 2 neutral- BEARISH 6-KOct 13, 2026
Medirom Healthcare Technologies Inc. disclosed receipt of a Nasdaq deficiency notice for failing…
Monitor the stock's bid price closely for any sustained recovery above $1.00. The Form 20-F deadline of November 11, 2026 is the nearer-term catalyst — failure to file could trigger additional…
- BEARISH 6-KAug 7, 2026
Medirom Healthcare Technologies (MRM) disclosed that Nasdaq granted an extension until November…
Monitor for the Form 20-F filing ahead of the November 11, 2026 deadline. Delisting risk remains high for this micro-cap issuer; any further delays or negative financial disclosures in the 20-F…
- NEUTRAL 6-KJun 25, 2026
MEDIROM MOTHER Labs, a subsidiary of Medirom Healthcare Technologies, received an additional order…
Monitor next quarterly report for revenue contribution from this expanded deployment. Without dollar amounts, near-term stock impact is limited.
- BEARISH 6-KMay 29, 2026
Medirom Healthcare Technologies disclosed receipt of a Nasdaq deficiency notice for failing to…
Monitor for the company's compliance plan submission by July 27, 2026 and any subsequent Form 20-F filing. Failure to file could trigger delisting proceedings, severely impacting liquidity and…
All MRM filing & press-release reports (6)
- 6-K reportOct 13, 2026
- 6-K reportAug 7, 2026
- 6-K reportJun 25, 2026
- 6-K reportMay 29, 2026
- PRESS-RELEASE reportMay 28, 2026
- 6-K reportMay 28, 2026